Prizidilol (SK & F 92657), a new vasodilator with beta-blocking properties in the treatment of essential hypertension

Author:

L�scher T.,Havelka J.,Greminger P.,Tuma J.,T�uber M.,Siegenthaler W.,Vetter W.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Reference23 articles.

1. Bell A, Boyce MJ, Burland WL, Underwood PD (1980) Assessment in man of SK & F 92657 a novel antihypertensive compound with vasodilator and ?-adrenoceptor blocking activity. Br J Clin Pharmacol 9: 299?300

2. Boyce M (1979) Volunteer studies with SK & F 92657, a novel antihypertensive agent with vasodilator and ?-adrenoceptor blocking activity. Abstract 308. 6th Scientific meeting of the International Society of Hypertension, Göteborg 1980

3. Clancy A, Steiner JA, Manghani K, James IM (1981) Cardiovascular effects of SK & F 92657, a new antihypertensive agent with ?-adrenoceptor antagonist and vasodilator properties. Br J Clin Pharmacol 11: 428

4. Collier JW, Pitcher DW (1980) Effects of SK & F 92657 on the superficial hand veins and forearm arterioles of man. Br J Clin Pharmacol 10: 567?571

5. Edmonstone WM, Manghani KK, Bell AJ, McLeod M, Milton-Thompson GJ, Burland WL (1981) Cardiovascular effects in man of intravenous prizidilol hydrochloride (SK & F 92657) a new antihypertensive agent. Br J Clin Pharmacol 12: 567?572

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3